Bullfrog AI Holdings, Inc. BFRG 深 滬
等待開盤 10-08 09:30:00 美东时间
1.50
0.000
0.00%
華盛通- 最 高1.51
- 今 開1.50
- 成交量 10.02万股
- 最 低 1.43
- 昨 收 1.50
- 總市值 1512.20万
- 52周最高 4.84
- 市盈率 靜 --
- 換手率 0.99%
- 52周最低 1.09
- 委 比 6.95%
- 總股本 1008.13万
- 歷史最高 9.50
- 量 比 0.64
- 振 幅 5.33%
- 歷史最低 1.09
- 每 手 1
- 風險率 0.51%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Bullfrog AI Holdings Expands Its Internal Sales Team To Support The Accelerated Commercialization Of Its Clinical Trial Optimization Solutions, Including Recently Launched bfPREP Module
BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence ("AI") and machine learning to enable the successful
09-30 20:07
BullFrog AI Expands Sales and Marketing Team to Accelerate Commercial Adoption of Clinical Trial Optimization Solutions and bfPREP™ Module
BullFrog AI Holdings, Inc. announced the expansion of its internal sales team to accelerate the commercialization of its clinical trial optimization tools, including the recently launched bfPREP™ module. This expansion complements the company's partnership with Sygnature Discovery, which focuses on selling BullFrog Data Networks™ solutions to global biopharma clients. The enhanced sales capabilities aim to strengthen direct marketing efforts for ...
09-30 12:00
BullFrog AI to Showcase AI-Powered Clinical Data Solutions in Xtalks Webinar
BullFrog AI's Director of AI, Juan Felipe Beltrán Lacouture, PhD, will present a webinar on "Clinical Data Analysis with Agents: Reliable Automation with Human Oversight" on October 6, 2025. The webinar will showcase how BullFrog AI's platforms, bfPREP™ and bfLEAP™, transform unstructured clinical data into structured datasets for advanced analysis. Key topics include leveraging AI for data extraction, aligning concepts to standardized vocabulari...
09-23 12:00
BullFrog AI Enters $10M Common Stock Purchase Agreement With Lincoln Park Capital
On September 15, 2025, BullFrog AI Holdings, Inc. (the "Company") entered into a purchase agreement (the "Purchase Agreement") and a registration rights agreement (the "Registration Rights Agreement"), with Lincoln Park
09-17 04:55
BullFrog AI’s bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration
BullFrog AI collaborates with Eleison Pharmaceuticals to advance oncology treatments, developing a new data ingestion module, bfPREP™, which successfully processed over 10,000 clinical trial PDFs into a standardized dataset. Leveraging its AI platform, BullFrog enhanced data analysis, identifying patient subgroups for optimized trial design and market positioning. The companies are preparing a joint conference submission and exploring further col...
09-08 12:00
BullFrog AI Faces Nasdaq Non-Compliance Notice
BullFrog AI Holdings, Inc. ( ($BFRG) ) just unveiled an announcement. On August...
08-28 05:01
Bullfrog AI Hldgs Q2 EPS $(0.15) Up From $(0.20) YoY, Sales $33.257K
Bullfrog AI Hldgs (NASDAQ:BFRG) reported quarterly losses of $(0.15) per share. This is a 25 percent increase over losses of $(0.20) per share from the same period last year. The company reported $33.257 thousand in
08-14 05:49
BullFrog AI to Present at BTIG Annual Virtual Biotechnology Conference
BullFrog AI Holdings, Inc. CEO Vin Singh will participate in a fireside chat and one-on-one meetings at BTIG’s Annual Virtual Biotechnology Conference on July 30, 2025, at 11:20 a.m. ET. The company leverages AI and machine learning to advance drug discovery and reduce clinical trial failures. For more information, contact BFRG@redchip.com.
07-28 20:30
Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development
BullFrog AI introduces its proprietary bfLEAP™ platform, designed to address challenges in biopharma R&D by leveraging biologically grounded AI. The platform, derived from Johns Hopkins technology, enhances therapeutic success through actionable insights at every drug development stage. Unlike generic AI models, bfLEAP™ handles complex biomedical data and compositional variables, addressing issues that cause 90% of drug candidates to fail in tria...
07-22 12:00
Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on July 23
BullFrog AI Holding,一家利用人工智能（AI）和机器学习技术推动药物开发的公司，将于7月23日举办网络研讨会，介绍其AI驱动平台，包括新模块bfPREP™，以及与Sygnature Discovery的合作，并探讨其在全球生物制药研发市场中的增长潜力。活动免费，注册及问题提交可通过提供的链接完成。
07-18 13:00
